Skip to content
  • Home
  • Catuvab®
  • R&D
  • Technology
  • About Us
  • Business Development
  • Contact
  • Imprint
  • Privacy Policy
  • Technology
  • CATUVAB®
  • R&D
  • About Us
    • Business Development
    • News
  • Technology
  • CATUVAB®
  • R&D
  • About Us
    • Business Development
    • News
Contact Us

Day: August 29, 2025

New Multicenter Study Confirms: CATUVAB® Safely Removes Tumor Cells from Salvaged Blood

Clinical study confirms CATUVAB® safely removes tumor cells from salvaged blood—paving the way for safer autologous transfusions in cancer surgery.

Subscribe

our blog

Stay informed about innovative blood care solutions tailored for your health and well-being.

By clicking Sign Up, you agree to our Terms and Conditions.

  • Imprint
  • Privacy Policy
  • News
Get in touch
  • Lindis Blood Care GmbH
    Neuendorfstrasse 18b
    16761 Hennigsdorf
    Germany
  • Follow us on LinkedIn
  • Send a message
Information
  • Technology
  • CATUVAB®
  • Research
  • About Us
  • Business Development

© Lindis Bloodcare. All Rights Reserved

Back to top